Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
In: BMJ: British Medical Journal, Jg. 379 (2022-11-19), Heft 8361, S. 1-9
academicJournal
Zugriff:
Titel: |
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
|
---|---|
Autor/in / Beteiligte Person: | Jardine, Meg J. ; Kotwal, Sradha S. ; Bassi, Abhinav ; Hockham, Carinna ; Jones, Mark ; Wilcox, Arlen ; Pollock, Carol ; Burrell, Louise M. ; McGree, James ; Rathore, Vinay ; Jenkins, Christine R. ; Gupta, Lalit ; Ritchie, Angus ; Bangi, Ashpak ; D'Cruz, Sanjay ; McLachlan, Andrew J. ; Finfer, Simon ; Cummins, Michelle M. ; Snelling, Thomas ; Jha, Vivekanand |
Zeitschrift: | BMJ: British Medical Journal, Jg. 379 (2022-11-19), Heft 8361, S. 1-9 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1756-1833 (print) |
DOI: | 10.1136/bmj-2022-072175 |
Schlagwort: |
|
Sonstiges: |
|